• 首頁> 新聞動態> 易特科集團與嘉盛集團簽約霧化器項目戰略合作

    易特科集團與嘉盛集團簽約霧化器項目戰略合作

    2021-06-11 11:04

    2021年6月10日,深圳市易特科投資控股有限公司與湖南嘉盛電陶新材料股份有限公司在深圳國際創新谷簽署了“電子煙霧化器項目”的戰略合作備忘錄,雙方本著“資源整合、優勢互補、共贏發展”的原則,將在“電子煙霧化器”領域展開全面深入合作,重點面向美國市場的電子煙霧化器(Vaporizer煙具)、日本市場加熱不燃燒電子煙煙具和煙彈(HNB Iqos 和 E-Pipe),攜手共同進行相關產品的研發及市場拓展。易特科集團董事長兼CEO張貫京先生、副董事長兼CFO肖應芬女士、聯合創始人兼CTO葛新科博士、執行總裁康萌女士、戰略合作業務總監趙立先生、技術研發總監蘇超英先生、投資副總監彭凌霖先生等核心團隊,與到訪的嘉盛集團聯合創始人鄧朝輝先生、嘉盛集團副總裁邱業歡先生、嘉盛智因大健康科技總經理章雪麗女士、嘉盛智因大健康科技常務副總經理李宜疆先生、奧楚科技總經理陳楚輝先生等管理團隊共同見證了這一時刻!



    嘉盛電陶新材料股份有限公司成立于2004年,是一家在霧化科技領域的領先企業,公司先后與湖南大學、中國地質大學、武漢理工大學、北京工業大學、國防科大等大專院校合作,長期聘請相關專家教授作為技術顧問。同時組建并培養了一支經驗豐富的工程技術經營團隊。公司目前核心產品為低膨脹系數電子結構陶瓷,主要領域為家電、新型煙草、醫療器械產品的核心部件。掌握全球唯一的脂溶性超聲霧化技術以及新一代加熱陶瓷霧化技術,主要涉及應用于新型煙草與大健康領域的霧化核芯及各領域霧化應用的電子設備。公司下設8家子公司,依托母公司嘉盛電陶的技術優勢,圍繞超聲霧化技術,聚焦大健康和新型煙草領域,為各產業客戶提供全球領先的多樣性霧化解決方案。




    易特科投控(安測健康)聚焦醫療信息化及醫療智能化,持續創新產品,升級了智慧健康全流程管理系統、智慧醫養管理平臺、智慧醫院云信息系統、智慧影像輔助判讀平臺和智慧中醫輔助辨識平臺五大核心產品線,產品結構不斷優化,技術優勢日益凸顯!


    在各界朋友的合作支持下,易特科投控(安測健康)不斷加強關鍵核心技術攻關;作為華為全球生態合作伙伴,AI慢病管理系統入選華為云嚴選方案,鯤鵬云ARM架構,ISV;與清華大學簽署智慧醫療研發創新戰略合作協議;安測肺病醫療影像輔助診斷系統正多家綜合醫院進行合作研究,未來將全面推動我國肺癌精準醫學事業發展;全力推進“大灣區中醫科學院”建設,由院士牽頭,以國醫大師和科學家為核心團隊,會聚國內著名中醫科研院所及信息科技公司,以生命科學、信息科技、人工智能為手段,探索人體生理病理、規范中醫診斷標準、提升中醫診療水平,將創新科技融入中醫,讓現代中醫走向世界!

    憑借在“AI+醫療、AI+健康、AI+養老”領域的高科技產品、人工智能技術、知識產權創新、產業化優勢和近三年營收規模復合高速增長,易特科投控(安測健康)榮獲德勤中國主辦評選的2020“中國高科技高成長企業50強”與“深圳高科技高成長企業20強”、招商證券的“羚躍計劃”、招商銀行“新動能基金”重點推薦企業、國家知識產權優勢企業、深圳質量百強企業、兩項技術獲第21屆中國專利優秀獎,累計獲得6項中國專利優秀獎,知識產權總量超過3100項、AI慢病管理系統榮獲深圳市科技進步二等獎……安測健康產品創新、技術創新和知識產權創新實力獲得社會各界認可,創新實力在智慧醫療領域全國領先!目前安測健康產品及服務已進入全國650多家公立醫療機構和450多家社康中心,產品競爭力、產品成熟度、市場接受度、品牌影響力、議價能力等方面均顯著提升!



    基于易特科投控在醫療科技領域有深厚技術積累并且是一個高度國際化的公司,而且在日本和美國擁有電子煙(霧化器)領域的專業渠道和投資商伙伴;湖南嘉盛公司在電子煙霧化器領域擁有深厚技術積淀和實力,為此合作雙方為布局海外電子煙領域,開展電子煙相關業務,進行了深度的資源整合,實現優勢互補,建立起穩固、多維度的戰略合作伙伴關系,進一步做大做強美國和日本電子煙市場的供應鏈,為海外合作伙伴做好技術和產品支撐。



    On June 10, 2021, E-techco Group and Hunan Jiasheng Diantao New Materials Co., Ltd. signed a strategic cooperation memorandum on "Vaporizer Project" in Shenzhen International Innovation Valley. Based on the principle of "resource integration, complementary advantages and win-win development", the two sides will carry out comprehensive and in-depth cooperation in the field of "Vaporizer", Focus on the U.S. market, and HNB iqos  for the Japanese market.Two parites will work together to develop related products and expand the market. Mr. Zhang guanjing, Chairman and CEO of E-techco Group, Ms. Kang Meng, CEO, Ms. Xiao Yingfen, vice chairman and CFO, Dr. Ge Xinke, co-founder and CTO, Mr. Zhao Li, director of strategic cooperation business, Mr. Su Chaoying, director of technical research and development, , Mr. Peng Linglin, deputy director of investment and other core teams, have witnessed this moment together with the visiting management teams, including Mr. Deng Chaohui, co-founder of Jiasheng Group, Mr. Qiu yehuan, vice president of Jiasheng Group, Ms. Zhang Xueli, general manager of Jiasheng Zhiyin Health Technology, Mr. Li Yijiang, executive deputy general manager of Jiasheng Zhiyin Health Technology, and Mr. Chen Chuhui, general manager of Aochu Technology!

    Jiasheng Diantao New Material Co., Ltd., founded in 2004, is a leading enterprise in the field of atomization technology. The company has cooperated with Hunan University, China University of Geosciences, Shanghai Institute of Silicate, Chinese Academy of Sciences, Wuhan University of technology, Beijing University of technology, National Defense University and other colleges, and has long employed relevant experts and professors as technical consultants. At the same time, Jiasheng has established and trained an experienced engineering technology management team. At present, the company's core products are Low Expansion Coefficient Electronic Structural Ceramics, mainly in the fields of home appliances, new tobacco, and core components of medical devices. Jiasheng also masters the world's only Fat Soluble Ultrasonic Atomization technology and the new generation of Heated Ceramic Atomization technology, mainly involving the atomization core applied in the field of new tobacco and big health and electronic equipment applied in various fields. The company has eight subsidiaries, relying on the technical advantages of the parent company Jiasheng Group, focusing on the field of health industry and new tobacco around ultrasonic atomization technology, to provide global leading diversified atomization solutions for customers in various industries.


    E-Techco Group(Anycheck)focusing on medical information and medical intelligence, it have continuously innovated products, upgraded five core product lines, including intelligent health full process management system, intelligent medical care management platform, intelligent hospital cloud information system, intelligent image assistant interpretation platform and intelligent TCM auxiliary identification platform. The product structure is constantly optimized and the technical advantages are increasingly prominent!

    With the cooperation of friends from all walks of life, E-techco Group (Anycheck) has constantly strengthened key core technology to solve key problems; As Huawei global ecological partner, AI slow disease management system is selected as Huawei Cloud Strict Selection Scheme, Kunpeng cloud arm architecture, ISV; Signed strategic cooperation agreement with Tsinghua University on smart medical R & D innovation; The medical imaging assisted diagnosis system of lung disease is cooperating with many general hospitals, which will promote the development of precision medicine of lung cancer in China in the future; We will make every effort to promote the construction of "Dawan District Academy of Traditional Chinese Medicine", led by academicians, and take the national medical masters and scientists as the core team, and gather well-known Chinese medicine research institutes and information technology companies in China. With the means of life science, information technology and artificial intelligence, we will explore human physiology and pathology, standardize the diagnosis and treatment standards of traditional Chinese medicine, improve the level of TCM diagnosis and treatment, and integrate innovative technology into traditional Chinese medicine, Let modern Chinese medicine go to the world!
     
    With the high-tech products, artificial intelligence technology, intellectual property innovation, industrialization advantages and the compound high-speed growth of revenue scale in the field of "AI+ medical, AI+ health and AI+ pension", E-Techco Group (Anycheck) won the 2020 "Top 50 High-tech and High-growth Enterprises of China" and "Top 20 High-tech and High-growth Enterprises in Shenzhen" sponsored by Deloitte China, The "Antelope Plan" of China Merchants Securities, key recommendation enterprises of "New Kinetic Energy Fund" of China Merchants Bank, “State-owned Enterprises with Intellectual Property Advantages”, “Top 100 Enterprises of Shenzhen Quality” and two technologies won the “21st China Patent Excellence Award”, and “6 Outstanding Chinese Patent awards” . With the total intellectual property rights exceeding 3100, its “AI Chronic Disease Management System” won the second prize of Shenzhen Science and technology progress. 

    Anycheck product’s innovation, technology innovation and intellectual property innovation strength have been recognized by all walks of life in the society, and the innovation strength is the leading in the field of intelligent medical treatment in China! At present, Anycheck products and services have entered more than 650 public medical institutions and more than 450 social health centers in China. The competitiveness of products, product maturity, market acceptance, brand influence and bargaining power have been significantly improved! 

    E-Techco Group has a deep technical accumulation in the field of medical technology and is a highly international company. It also has professional channels and investment partners in the field of electronic cigarette (Vaporizer) in Japan and the United States; Hunan Jiasheng Co., Ltd. has profound technical accumulation and strength in the field of Vaporizer. Therefore, in order to lay out the overseas e-cigarette field and carry out e-cigarette related business, the two sides have carried out in-depth resource integration, realized complementary advantages, established a solid and multi-dimensional strategic cooperative partnership, and further expanded and strengthened the supply chain of e-cigarette markets in the United States and Japan, Provide technical and product support for overseas partners.

    按年份查詢

    全部

    2021

    2020

    2019

    2018

    2017

    2016

    2015

    2014

    2013

    搜索

    在线彩票购买 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>